8 Aptamers for the Diagnosis of Infectious Diseases
233
fabrication, improvement and application. It can be anticipated that aptamers will
play a pivotal role in the future development of advanced diagnostic techniques of
intricate infectious diseases (Table 8.7).
References
1. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, Daszak P (2008) Global
trends in emerging infectious diseases. Nature 451(7181):990–993
2. Park KS (2018) Nucleic acid aptamer-based methods for diagnosis of infections. Biosens
Bioelectron 102:179–188
3. Morens DM, Fauci AS (2013) Emerging infectious diseases: threats to human health and
global stability. PLoS Pathog 9(7):e1003467
4. Molefe P, Masamba P, Oyinloye B, Mbatha L, Meyer M, Kappo A (2018) Molecular application of aptamers in the diagnosis and treatment of cancer and communicable diseases.
Pharmaceuticals 11 (4)
5. Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S,
Tomba GS, Wallinga JJP (2008) Social contacts and mixing patterns relevant to the spread of
infectious diseases. PLoS Med 5(3):e74
6. Mazar J, Li Y, Rosado A, Phelan P, Kedarinath K, Parks GD, Alexander KA, Westmoreland
TJ (2018) Zika virus as an oncolytic treatment of human neuroblastoma cells requires CD24.
PLoS ONE 13(7):e0200358
7. Yang S, Wu J, Ding C, Cui Y, Zhou Y, Li Y, Deng M, Wang C, Xu K, Ren J, Ruan B, Li L
(2017) Epidemiological features of and changes in incidence of infectious diseases in China
in the first decade after the SARS outbreak: an observational trend study. Lancet Infect Dis
17(7):716–725
8. Cyranoski DJN (2017) SARS outbreak linked to Chinese bat cave. Nature 552:15–16
9. Nkengasong J (2020) China’s response to a novel coronavirus stands in stark contrast to the
2002 SARS outbreak response. Nat Med 26(3):310–311
10. Du Toit A (2018) Continued risk of Ebola virus outbreak. Nat Rev Microbiol 16(9):521
11. Bornholdt ZA, Turner HL, Murin CD, Li W, Sok D, Souders CA, Piper AE, Goff A, Shamblin
JD, Wollen SEJS (2016) Isolation of potent neutralizing antibodies from a survivor of the 2014
Ebola virus outbreak. Science 351(6277):1078–1083
12. Li G, De Clercq E (2020) Therapeutic options for the 2019 novel coronavirus (2019-nCoV).
Nat Rev Drug Discov 19(3):149–150
13. McGuinness WA, Malachowa N, DeLeo F (2017) Focus: infectious diseases: vancomycin
resistance in Staphylococcus aureus. N Engl J Med 90(2):269
14. Gagneux S (2018) Ecology and evolution of Mycobacterium tuberculosis. Nat Rev Microbiol
16(4):202
15. Hethcote HW (2000) The mathematics of infectious diseases. SIAM Rev Soc Ind Appl Math
42(4):599–653
16. Schnadig VB (2017) Cytopathology of infectious and inflammatory diseases. Elsevier Inc.,
New York, pp 22–80
17. Yang S, Rothman RE (2004) PCR-based diagnostics for infectious diseases: uses, limitations,
and future applications in acute-care settings. Lancet Infect Dis 4(6):337–348
18. Mahony JB (2014) Nucleic acid amplification-based diagnosis of respiratory virus infections.
Expert Rev Anti Infect Ther 8(11):1273–1292
19. Mori Y, Notomi T (2009) Loop-mediated isothermal amplification (LAMP): a rapid, accurate,
and cost-effective diagnostic method for infectious diseases. J Infect Chemother 15(2):62–69
20. Dunn MR, Jimenez RM, Chaput JC (2017) Analysis of aptamer discovery and technology.
Nat Rev Chem 1(10):0076
233
fabrication, improvement and application. It can be anticipated that aptamers will
play a pivotal role in the future development of advanced diagnostic techniques of
intricate infectious diseases (Table 8.7).
References
1. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, Daszak P (2008) Global
trends in emerging infectious diseases. Nature 451(7181):990–993
2. Park KS (2018) Nucleic acid aptamer-based methods for diagnosis of infections. Biosens
Bioelectron 102:179–188
3. Morens DM, Fauci AS (2013) Emerging infectious diseases: threats to human health and
global stability. PLoS Pathog 9(7):e1003467
4. Molefe P, Masamba P, Oyinloye B, Mbatha L, Meyer M, Kappo A (2018) Molecular application of aptamers in the diagnosis and treatment of cancer and communicable diseases.
Pharmaceuticals 11 (4)
5. Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S,
Tomba GS, Wallinga JJP (2008) Social contacts and mixing patterns relevant to the spread of
infectious diseases. PLoS Med 5(3):e74
6. Mazar J, Li Y, Rosado A, Phelan P, Kedarinath K, Parks GD, Alexander KA, Westmoreland
TJ (2018) Zika virus as an oncolytic treatment of human neuroblastoma cells requires CD24.
PLoS ONE 13(7):e0200358
7. Yang S, Wu J, Ding C, Cui Y, Zhou Y, Li Y, Deng M, Wang C, Xu K, Ren J, Ruan B, Li L
(2017) Epidemiological features of and changes in incidence of infectious diseases in China
in the first decade after the SARS outbreak: an observational trend study. Lancet Infect Dis
17(7):716–725
8. Cyranoski DJN (2017) SARS outbreak linked to Chinese bat cave. Nature 552:15–16
9. Nkengasong J (2020) China’s response to a novel coronavirus stands in stark contrast to the
2002 SARS outbreak response. Nat Med 26(3):310–311
10. Du Toit A (2018) Continued risk of Ebola virus outbreak. Nat Rev Microbiol 16(9):521
11. Bornholdt ZA, Turner HL, Murin CD, Li W, Sok D, Souders CA, Piper AE, Goff A, Shamblin
JD, Wollen SEJS (2016) Isolation of potent neutralizing antibodies from a survivor of the 2014
Ebola virus outbreak. Science 351(6277):1078–1083
12. Li G, De Clercq E (2020) Therapeutic options for the 2019 novel coronavirus (2019-nCoV).
Nat Rev Drug Discov 19(3):149–150
13. McGuinness WA, Malachowa N, DeLeo F (2017) Focus: infectious diseases: vancomycin
resistance in Staphylococcus aureus. N Engl J Med 90(2):269
14. Gagneux S (2018) Ecology and evolution of Mycobacterium tuberculosis. Nat Rev Microbiol
16(4):202
15. Hethcote HW (2000) The mathematics of infectious diseases. SIAM Rev Soc Ind Appl Math
42(4):599–653
16. Schnadig VB (2017) Cytopathology of infectious and inflammatory diseases. Elsevier Inc.,
New York, pp 22–80
17. Yang S, Rothman RE (2004) PCR-based diagnostics for infectious diseases: uses, limitations,
and future applications in acute-care settings. Lancet Infect Dis 4(6):337–348
18. Mahony JB (2014) Nucleic acid amplification-based diagnosis of respiratory virus infections.
Expert Rev Anti Infect Ther 8(11):1273–1292
19. Mori Y, Notomi T (2009) Loop-mediated isothermal amplification (LAMP): a rapid, accurate,
and cost-effective diagnostic method for infectious diseases. J Infect Chemother 15(2):62–69
20. Dunn MR, Jimenez RM, Chaput JC (2017) Analysis of aptamer discovery and technology.
Nat Rev Chem 1(10):0076